The letters, many of which were already available online, detail why the regulators initially declined to approve some drugs.

In 2024, scientists stumbled upon a potential new treatment for hereditary-patterned baldness, the most common cause of hair ...

Balanced testosterone levels are essential to fertility, well-being, and general health. Learn the symptoms, causes, and ...

This represents a burgeoning American health trend. Between 2019 and 2024 prescriptions for testosterone jumped from 7.3m to ...

Bayer's venerable testosterone replacement product for men with hypogonadism – Nebido – is being sold to Grünenthal as the group continues a revamp of its healthcare business. Grünenthal is ...

Lantheus has filed what it says is the first generic version of Novartis’ big-selling cancer radionuclide therapy Lutathera in the US, used to treat rare neuroendocrine tumours (NETs). The FDA ...